Skip to main content
Clinical Trials/NCT03483155
NCT03483155
Unknown
Not Applicable

Compliance With The European Society Of Cardiology Prevention Guidelines In Patients at High Cardiovascular Disease Risk in Assiut University

Assiut University0 sites50 target enrollmentApril 15, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Assiut University
Enrollment
50
Primary Endpoint
the incidence of Cardiovascular disease
Last Updated
8 years ago

Overview

Brief Summary

Patients with coronary or other atherosclerotic cardiovascular disease and those at high risk of developing cardiovascular disease have been defined as the highest clinical priorities for prevention

Detailed Description

Cardiovascular disease prevention programs are designed to reduce patients' morbidity and mortality.the European society of cardiology with other partner societies has engaged in a comprehensive programme of cardiovascular disease prevention in clinical practice aimed to improve practice of preventive cardiology by encouraging the development of national guidance on cardiovascular disease prevention

Registry
clinicaltrials.gov
Start Date
April 15, 2018
End Date
September 15, 2019
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Noran Mohamed

Compliance With The European Society Of Cardiology Prevention Guidelines In Patients at High Cardiovascular Disease Risk in Assiut University

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Patients having signed an informed Consent Patients aged from 18 to 80 years old at the time of identification At least six and at most 24 months elapsed between the index event (the recruiting diagnostic or treatment criteria below) and the date of interview Patients meeting the recruiting diagnostic or treatment criteria: High CVD risk patients: patients free of CVD, who have been prescribed one or more of the following treatments: blood pressure and/or lipid-lowering and/or glucose lowering (diet and/or oral hypoglycaemic agents)

Exclusion Criteria

  • Patients living outside defined geographical area (Assiut Governorate)

Outcomes

Primary Outcomes

the incidence of Cardiovascular disease

Time Frame: 18 months

occurrence of any cardiovascular affection

Similar Trials